Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
PaperCitations, authors & open-access status
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,094 citations, 2018 year and green oa status.
2,094
Citations
2018
Year
green
OA Status